128 related articles for article (PubMed ID: 35970854)
1. Intravitreal bevacizumab injection for retinopathy of prematurity and pulmonary hypertension.
Park L; Donohue L; Lakshminrusimha S; Sankaran D
J Perinatol; 2023 Feb; 43(2):236-237. PubMed ID: 35970854
[No Abstract] [Full Text] [Related]
2. Is Anti-Vascular Growth Factor Therapy for Retinopathy of Prematurity Associated With Pulmonary Hypertension?
Kumar VHS
JAMA Ophthalmol; 2023 Apr; 141(4):407-408. PubMed ID: 36862405
[No Abstract] [Full Text] [Related]
3. Is Anti-Vascular Growth Factor Therapy for Retinopathy of Prematurity Associated With Pulmonary Hypertension?
Raghuveer TS; Zackula RE; Okut H
JAMA Ophthalmol; 2023 Apr; 141(4):406-407. PubMed ID: 36862404
[No Abstract] [Full Text] [Related]
4. Is Anti-Vascular Growth Factor Therapy for Retinopathy of Prematurity Associated With Pulmonary Hypertension?
Chiang PH; Lin CC
JAMA Ophthalmol; 2023 Apr; 141(4):407. PubMed ID: 36862391
[No Abstract] [Full Text] [Related]
5. Is Anti-Vascular Growth Factor Therapy for Retinopathy of Prematurity Associated With Pulmonary Hypertension?-Reply.
Nitkin CR; Richardson T; Lewis T
JAMA Ophthalmol; 2023 Apr; 141(4):408-409. PubMed ID: 36862400
[No Abstract] [Full Text] [Related]
6. Bevacizumab for retinopathy of prematurity and neurodevelopment.
Wallace DK;
J AAPOS; 2024 Feb; 28(1):103786. PubMed ID: 37926389
[No Abstract] [Full Text] [Related]
7. Bevacizumab for retinopathy of prematurity and neurodevelopment.
Binenbaum G
J AAPOS; 2023 Feb; 27(1):1-2. PubMed ID: 36623638
[No Abstract] [Full Text] [Related]
8. Re: Freedman et al: Low- and very low-dose bevacizumab for retinopathy of prematurity: reactivations, additional treatments, and 12-month outcomes (Ophthalmology. 2022;129:1120-1128).
Asensio-Sánchez VM
Ophthalmology; 2023 May; 130(5):e18. PubMed ID: 36702728
[No Abstract] [Full Text] [Related]
9. Fundus Pigmentation in the Diagnosis and Treatment of Retinopathy of Prematurity.
Fan KC; Read SP; Patel NA; Vanner EA; Al-Khersan H; Laura DM; Pakravan P; Negron CI; Berrocal AM
Ophthalmology; 2021 Aug; 128(8):1242-1244. PubMed ID: 33383092
[TBL] [Abstract][Full Text] [Related]
10. Refractive outcome of intravitreal bevacizumab injection in comparison to spontaneous regression of retinopathy of prematurity (ROP).
Etezad Razavi M; Shoeibi N; Hassanzadeh S; Kianmehr S; Bakhtiari E
Strabismus; 2020 Mar; 28(1):49-54. PubMed ID: 31790628
[No Abstract] [Full Text] [Related]
11. Efficacy of intravitreal bevacizumab for zone-II retinopathy of prematurity.
Karkhaneh R; Khodabande A; Riazi-Eafahani M; Roohipoor R; Ghassemi F; Imani M; Dastjani Farahani A; Ebrahimi Adib N; Torabi H
Acta Ophthalmol; 2016 Sep; 94(6):e417-20. PubMed ID: 27009449
[TBL] [Abstract][Full Text] [Related]
12. A lower dose of intravitreal bevacizumab effectively treats retinopathy of prematurity.
Khodabande A; Niyousha MR; Roohipoor R
J AAPOS; 2016 Dec; 20(6):490-492. PubMed ID: 27794470
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal Bevacizumab for Retinopathy of Prematurity: Another Hit to the Immature Lung?
Oulego-Erroz I; Alonso-Ojembarrena A
Chest; 2022 Dec; 162(6):1231-1232. PubMed ID: 36494122
[No Abstract] [Full Text] [Related]
14. OUTCOMES OF NONCONFLUENT DIODE LASER PANRETINAL PHOTOCOAGULATION FOR AGGRESSIVE POSTERIOR RETINOPATHY OF PREMATURITY AFTER INTRAVITREAL BEVACIZUMAB.
Mammo DA; Rubino SM; Quiram PA
Retina; 2021 Apr; 41(4):706-710. PubMed ID: 32796444
[TBL] [Abstract][Full Text] [Related]
15. Retinopathy of Prematurity: Intravitreal injections of bevacizumab: timing, technique, and outcomes.
Mintz-Hittner HA
J AAPOS; 2016 Dec; 20(6):478-480. PubMed ID: 27816750
[No Abstract] [Full Text] [Related]
16. A rare association of intravitreal bevacizumab injection with double ridge formation in retinopathy of prematurity.
Yaz Y; Erol N; Gursoy H; Basmak H; Bilgec MD
J Pediatr Ophthalmol Strabismus; 2014 Oct; 51 Online():e66-8. PubMed ID: 25333243
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary Hypertension and Anti-Vascular Endothelial Growth Factor Therapy for Retinopathy of Prematurity-Is There a Link?
Patel SN
JAMA Ophthalmol; 2022 Nov; 140(11):1094-1095. PubMed ID: 36201187
[No Abstract] [Full Text] [Related]
18. Intravitreal bevacizumab for retinopathy of prematurity: Considerations for informed consent.
Mireskandari K; Collins ME; Tehrani N
Can J Ophthalmol; 2015 Dec; 50(6):409-12. PubMed ID: 26651298
[No Abstract] [Full Text] [Related]
19. Very Late Reactivation of Retinopathy of Prematurity After Monotherapy With Intravitreal Bevacizumab.
Snyder LL; Garcia-Gonzalez JM; Shapiro MJ; Blair MP
Ophthalmic Surg Lasers Imaging Retina; 2016 Mar; 47(3):280-3. PubMed ID: 26985803
[TBL] [Abstract][Full Text] [Related]
20. [Neurodevelopment in patients with retinopathy of prematurity treated with intravitreal bevacizumab. Case series].
Martínez-García SM; Hernández-Da Mota SE; Rubio-Rangel A; Rojas-Flores I; Vieyra-López ME; Martínez-Castellanos MA; Zavala-Martínez MT; Gómez García A
Cir Cir; 2017; 85(6):478-484. PubMed ID: 28110900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
